Post Operative Urinary Retention (POUR) Following Thoracic Oncological

Status Recruiting

Clinical Trial Summary

This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.

Clinical Trial Description

Post-operative urinary retention (POUR) is a significant problem in post-operative patients. The incidence varies, but can reach up to 70%, which most commonly affects older men with enlarged prostates. Even after adjusting for the modifiable risk factors, such as decreased intraoperative foley use and post-operative narcotic use, the incidence remains high. This causes an increase in urinary tract infections, patient discomfort, longer hospital stays, and occasionally further urologic complications. Studies have shown that the use of tamsulosin, an alpha1-adrenergic receptor blocker, may decrease the incidence of POUR by improving urinary flow via relaxation of the smooth muscle tissue. Therefore, the goal of our study is to investigate whether Tamsulosin (Flomax) can be used to lower incidence of POUR in older men undergoing an oncological thoracic surgical procedure. This is a pilot/feasibility/ early efficacy study to determine if treating men > 55 years of age with Tamsulosin prior to a thoracic oncological surgery will prevent postoperative urinary retention (POUR). Subjects will be provided with a prescription for Tamsulosin (generic) to be taken 7 days prior to scheduled surgery. For research purposes, post-surgical spontaneous voids will be measured, and any residual urine in the bladder will be assessed and measured using a BladderScanner. This data will be used to determine postoperative urinary retention (POUR). Additionally, standard of care bladder management will be used if the subject did not spontaneously void or had excess urine residual. The algorithm in the table below will guide bladder management decisions. ;

Study Design

Related Conditions & MeSH terms

Urinary Retention

Clinical Trial Details

NCT number	NCT05657990
Study type	Interventional
Source	Hackensack Meridian Health
Contact	Denise Theiler, RN
Phone	7327763301
Email	Denise.Theiler@hmhn.org
Status	Recruiting
Phase	Early Phase 1
Start date	April 3, 2023
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT05538273` - Optimal Management of Urinary Catheter in Gyn Onc
Recruiting	`NCT05065255` - Study of the Criteria for Choosing Speedicath Catheters During the Initiation of Self-catheterization
Completed	`NCT04236596` - Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention	N/A
Completed	`NCT05526651` - Improvement of Urinary Retention Symptoms With Electroacupuncture Therapy	N/A
Not yet recruiting	`NCT06070545` - The Effect of Modified Supine Position on Urinary Elimination After Percutaneous Coronary Intervention	N/A
Recruiting	`NCT03314025` - Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery	Phase 2
Recruiting	`NCT05439902` - Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women	N/A
Enrolling by invitation	`NCT05259800` - Peppermint Oil for Urinary Retention	N/A
Recruiting	`NCT06417346` - Comparison of Laparoscopic and Open Inguinal Hernia Repair in Elderly Patients	N/A
Completed	`NCT03296280` - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed	`NCT04715971` - Urinary Retention on an Acute Geriatric Hospitalisation Unit.
Completed	`NCT03302936` - Assessing Pyridium for Post-Sling Urinary Retention	Phase 4
Completed	`NCT02886143` - Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention	Phase 3
Completed	`NCT02749188` - Evaluation of Bladder Stimulation as a Noninvasive Technique of Urine Collection in Infant Who Have Not Acquired Walking	N/A
Completed	`NCT01284361` - Comparison of Two Intermittent Urinary Catheters	N/A
Completed	`NCT01220362` - Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled Study	N/A
Terminated	`NCT00804557` - Efficacy And Safety Of The Uro-Ease® Urinary Catheter During Clean Intermittent Catheterization	N/A
Terminated	`NCT00563654` - Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up	N/A
Terminated	`NCT00563485` - Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up	N/A
Terminated	`NCT04682366` - The Effect of Tamsulosin on Postoperative Urinary Retention	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms